Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kim

Showing results (191-200 of 512) with videos related to

Pageof 52
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2009
Short term results from GHRH analogue use in pre-menopausal breast cancer in KoreaH J Kim, J S Lee, E H Park, et al.
The Science of the Total Environment|May 12, 2017
Effects of in situ exposure to tritiated natural environments: A multi-biomarker approach using the fathead minnow, Pimephales promelasB Gagnaire, C Adam-Guillermin, A Festarini, et al.
Yonsei Medical Journal|November 24, 1999
The Korean collaborative study on 11,000 prenatal genetic amniocentesisY H Yang, K S Ju, S B Kim, et al.
Journal of Korean Medical Science|November 12, 1998
Severe aplastic anemia induced by ticlopidine: report of two casesH Bahng, J H Lee, C Suh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapyJ H Park, S F Jonas, G Bataillon, et al.
Bone Marrow Transplantation|January 18, 2005
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSFJ-L Lee, S Kim, S W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)H R Kim, K H Jung, S-A Im, et al.
Radiology|June 1, 1997
Benign and malignant esophageal strictures: treatment with a polyurethane-covered retrievable expandable metallic stentH Y Song, S I Park, H Y Jung, et al.
Journal of Korean Medical Science|June 1, 1996
Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institutionK H Lee, J S Lee, C W Suh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2020
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 studyP Schmid, R Salgado, Y H Park, et al.
Pageof 52

Showing results (191-200 of 512) with videos related to

Sort By:
Pageof 52
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 10, 2009
Short term results from GHRH analogue use in pre-menopausal breast cancer in KoreaH J Kim, J S Lee, E H Park, et al.
The Science of the Total Environment|May 12, 2017
Effects of in situ exposure to tritiated natural environments: A multi-biomarker approach using the fathead minnow, Pimephales promelasB Gagnaire, C Adam-Guillermin, A Festarini, et al.
Yonsei Medical Journal|November 24, 1999
The Korean collaborative study on 11,000 prenatal genetic amniocentesisY H Yang, K S Ju, S B Kim, et al.
Journal of Korean Medical Science|November 12, 1998
Severe aplastic anemia induced by ticlopidine: report of two casesH Bahng, J H Lee, C Suh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2019
Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapyJ H Park, S F Jonas, G Bataillon, et al.
Bone Marrow Transplantation|January 18, 2005
ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSFJ-L Lee, S Kim, S W Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2013
Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)H R Kim, K H Jung, S-A Im, et al.
Radiology|June 1, 1997
Benign and malignant esophageal strictures: treatment with a polyurethane-covered retrievable expandable metallic stentH Y Song, S I Park, H Y Jung, et al.
Journal of Korean Medical Science|June 1, 1996
Prognostic factors of acute myelocytic leukemia: an analysis of 132 patients in a single institutionK H Lee, J S Lee, C W Suh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2020
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 studyP Schmid, R Salgado, Y H Park, et al.
Pageof 52